NCT05442606

Brief Summary

This study aims to investigate the effect of adding of integrated physiotherapy program to the conservative medical therapy on quality of life and pressure pain threshold (PPT) in chronic rhinosinusitis patients. Patients in this study will be randomly assigned into 2 groups. Group A (control group) will receive conservative medical treatment only which prescribed by Ear, Nose and Throat (ENT) specialist, while group B (experimental group) will receive the conservative medical treatment prescribed by ENT specialist in addition to physiotherapy program. Quality of Life (QoL) will be evaluated by Rhinosinusitis Disability Index (RSDI) and PPT will be evaluated by digital algometer at the baseline and immediately after the end of tenth session of treatment for both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 5, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2023

Completed
Last Updated

October 26, 2023

Status Verified

October 1, 2023

Enrollment Period

6 months

First QC Date

June 26, 2022

Last Update Submit

October 24, 2023

Conditions

Keywords

Rhinosinusitisultrasound therapyquality of lifepain thresholdmanual therapy

Outcome Measures

Primary Outcomes (1)

  • Rhinosinusitis Disability Index (RSDI)

    Arabic version of Rhinosinusitis Disability Index will be used to assess the change in quality of life

    From baseline to 4 weeks after treatment (immediately after the completion of session 12)

Secondary Outcomes (1)

  • Pressure pain threshold

    From baseline to 4 weeks after treatment (immediately after the completion of session 12)

Study Arms (2)

Conservative medical therapy

NO INTERVENTION

Patients in this group received only medication prescribed by an Ear, Nose and Throat specialist.

Medication and Physiotherapy program

EXPERIMENTAL

Patients in this group received medication prescribed by an Ear, Nose and Throat specialist, in addition to integrated Physiotherapy program

Other: Ultrasound TherapyOther: Manual Drainage TechniquesOther: Self Sinus Massage Technique

Interventions

Using an Enraf Nonius Sonoplus 490 from the Netherlands, the patients were asked to lie supine while the therapist stood at the level of the patient's head. The patients received pulsed (duty cycle 50%) US therapy with intensities of 1 and 0.5 W/cm2 for maxillary and frontal sinus, respectively, and a collimating beam frequency of 1MHz. To deliver US to the treatment area, a small probe US applicator (0.8 cm2) with an effective radiating area (ERA) of 0.6 cm2 and a beam non-uniformity ratio (BNR) of 6:1 was used. The skin around the cheeks was used for the maxillary sinus and the forehead for the frontal sinus. Between the applicator and the skin, ultrasound transmission gel was employed, and a full contact technique in slow circular motion was used for 5 minutes over the maxillary sinuses and 4 minutes over the frontal sinuses on each pair of sinuses

Medication and Physiotherapy program

Manual Drainage Techniques for the frontal and maxillary sinuses

Medication and Physiotherapy program

Patients will also encouraged to self-massage their frontal and maxillary sinuses while resting supine

Medication and Physiotherapy program

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients of both sexes
  • Aged from 30 to 50 years
  • Cynically diagnosed by Ear, Nose, and Throat (ENT) specialist, with chronic rhinosinusitis with a history of more than 3 months, confirmed by clinical diagnostic criteria (more than or equal to two major symptoms or one major symptom (nasal obstruction, facial pain/pressure, postnasal drip and hyposmia) and two minor symptoms (headache, halitosis, fatigue, dental pain and ear pain) and also verified by Computed Tomography (CT) scan results .

You may not qualify if:

  • Having any tumors or cysts (as confirmed by CT scan)
  • Nasal polyps
  • Facial skin lesions or diseases or allergies of the face
  • Pregnancy
  • Metal implants in the face region
  • Previous nasal surgical procedures
  • Impaired thermal sensation (such as uncontrolled diabetes mellitus)
  • Cognitive level impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Qurayyat General Hospital

Qurayyat, Jouf Region, 77471, Saudi Arabia

Location

Related Links

MeSH Terms

Conditions

Rhinosinusitis

Interventions

Ultrasonic Therapy

Condition Hierarchy (Ancestors)

RhinitisRespiratory Tract InfectionsInfectionsSinusitisParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeutics

Study Officials

  • Khaled Fouda, PhD

    Associate Professor of Physical Therapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical therapy

Study Record Dates

First Submitted

June 26, 2022

First Posted

July 5, 2022

Study Start

September 1, 2022

Primary Completion

March 1, 2023

Study Completion

March 21, 2023

Last Updated

October 26, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

The IPD will be shared including a summary of the results after the study completion date.

Shared Documents
STUDY PROTOCOL
Time Frame
The dead time for IPD will be 30 June.2025
Access Criteria
will be uploaded on the official site of CTR
More information

Available IPD Datasets

Full Paper Access

Locations